14th Annual CABS BioPacific Conference 2012

Another excellent lineup of Biotech/Pharma speakers!!

To register, go to https://www.cabsweb.org/CABSweb/feventdue.jsp

Take advantage of CABS membership rates and additional member benefits for $30/year by joining CABS.For more information, please visit: www.BioPacificconference.org.

BioPacific Organizing Committee is working very hard to fulfill our promise for the delivering of an exciting program to our CABS members on June 2nd. We have updated the agenda (see below) with an expanded evening session on entrepreneurship and VC funding where the biotech veteran and VC visionary Kenneth Fong will deliver the opening remark. Additionally, we will introduce a new program, BioPac Partnering (TM) One-on-One Forum, to provide a platform for CABS members to pair up with their potential business partners and future employers during the conference. If you are interested in attending our annual event, please act now to take advantage of the early bird registration rate which will expire on May 19th (in less than two weeks). If you know your friends who might be interested in our program, please feel free to forward on.

Updated BioPacific Conference Agenda

8:00-9:00 am

Registration and Vendor Exhibits

9:00-9:05 am

Welcome Remarks

Wentao Zhang, Ph.D., CABS President-Elect, BioPacific Organizing Committee Chair

9:05-9:15 am

State of the Society

Janet Xiao, J.D., Ph.D., CABS President

Session I: Biopharmaceutical R&D Innovation: Trends, Successes & Challenges

Session Chairs: Connie Sun, Ph.D. & Charlene Liao, Ph.D.

9:15-9:40 am

Peter Hirth, Ph.D., CEO, Plexxikon

Personalized Medicine - Vemurafenib for the Treatment of V600 B-Raf Positive Metastatic Melanoma

9:40-10:05 am

Ann Lee, Ph.D., SVP, Genentech, Head of Global Technical Development, Roche

Process Technology and Manufacturing Innovations in Support of Drug Development

10:05-10:30 am

Susan Molineaux, Ph.D., Founder, President and CEO, Calithera

The Challenges of Building an Innovative Drug Discovery Biotech Company in Today's Economy

10:30-10:50 am

Break, Networking, and Vendor Exhibits

Session II: Breakthroughs in Biomedical Research and Drug Discovery

Session Chairs: Alan Hao, Ph.D. & Jiangwen Majeti, Ph.D., MBA

10:50-11:15 am

Rusty Williams, M.D., Ph.D., CEO, FivePrime

Discovery of New Ligand Trap and Antibody drugs

11:15-11:40 am

Philip Beachy, Ph.D., Ernest and Amelia Gallo Professor, Stanford University School of Medicine, Investigator, HHMI

The Hedgehog Pathway: Biology and Therapeutics

11:40-12:05 pm

Sasha Kamb, Ph.D., SVP, Discovery Research, Amgen

A Stronger Spine: Lessons from an Innovative Bone Drug

12:05-12:25 pm

Connie Sun, SVP, Oncology Services, Pharmaron, Gold Sponsor

Nathan Bach, BD Manager, GenScript, Gold Sponsor

12:25-1:25 pm

Lunch

Session III: Industry Collaborations: Rising Importance of Academia and Foundations

Session Chairs: Zhonghua Pei, Ph.D. & Chi-Hui Tang, Ph.D.

1:30-1:55 pm

Rick Lindberg, Ph.D., Head, Pfizer Centers for Therapeutic Innovation-California

CTI: A New Model for Accelerating Translation of Basic Science to the Clinic

1:55-2:15 pm

Keting Chu, M.D., Ph.D., VP, Leukemia & Lymphoma Society

Partnering with The Leukemia and Lymphoma Society

2:15-2:35 pm

Van Ellis, J.D., Partner, Morrison & Foerster LLP

The Rise of Industry-Academic Collaborations: Opportunities Amid Increased Funding Pressure

2:35-2:55 pm

Honggang Bi, VP, Covance, General Manger, Covance China, Gold Sponsor

Mingzhu Zhang, VP, Medicilon, Gold Sponsor

2:55-3:15 pm

Break, Networking, and Vendor Exhibits

Session IV: Landscape & Emerging Models in U.S./China Collaborations

Session Chairs: John Mao, Ph.D & Josh Xiao, Ph.D.

3:15-3:40 pm

Kenneth Hillan, M.D., Ph.D., CEO and CMO, Achaogen

Enter the Dragon

3:40-4:05 pm

Guo-Liang Yu, Ph.D., CEO and Chairman, Epitomics

Better antibodies, better science: the journey of Epitomics Inc.

4:05-4:30 pm

Qing Dong, Ph.D., CSO, Shanghai Hengrui Pharmaceutical Co.

Drug Discovery and Development in China: the Hengrui Experience

4:30-4:55 pm

Zhenping Zhu, M.D., Ph.D., Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation, and President and CEO of Kadmon China

New R&D Paradigm for Innovative Medicine

4:55-5:55 pm

Panel Discussion: Emerging U.S./China R&D Collaboration and Business Models

Moderator: Greg Scott, President and Founder, ChinaBio LLC

Panelists: Kenneth Hillan, Dong Qing, Guo-Liang Yu, Zhenping Zhu, and Chen Chen, CEO, Sundia Meditech, Rich Soll, SVP, WuXi AppTec

5:55-6:15 pm

Piu (Bill) Chan, President and CEO, Wincon Theracells, Gold Sponsor

Wayne Li, General Manager, Kunming Biomed International, Gold Sponsor

6:15-7:15 pm

Dinner

Session V: Entrepreneurship and Opportunities: West Meets East

Session Chairs: Wentao Zhang, Ph.D. & Hua Tu, Ph.D.

7:15-7:40 pm

Kenneth Fong, Ph.D., Chairman, Kenson Ventures, LLC

What Are Successful Biotech Entrepreneurs Made Of?

7:40-9:00 pm

Panel Discussion: Successful Entrepreneurship: Opportunities in the U.S. and China

Moderator: Josh Xiao, Ph.D.

Panelists: Guo-Liang Yu, and

Ben P. Chen, Managing Partner, Ignatius Transaction Partners

Wayne Li, Ph.D., Manager, Morningside Technologies (晨兴科技风险投资公司)

Cheng Liu, Ph.D., Founder and CEO, Eureka Therapeutics

Richard Liu, Chief Representative, Xi'an Hi-Tech Park （西安高新技术产业开发区驻美首席代表）

Wang Shen, Ph.D., Founder & CEO, Kanion USA

Alex Wu, Ph.D., Co-Founder and CEO, Crown Biosciences

Qiang Xu, Ph.D., Principal, Decheng Capital (德诚资本)

9:00 pm

Adjourn